In drug-naive first-episode SZ subjects, a significant decrease in IL-10 was observed, and there was an inverse correlation with negative symptoms from the PANSS scale [77], which could suggest a possible relation between IL-10 decrease and cognitive impairment. The gene discussed is IL10; the disease is Cognitive impairment.